These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8151263)

  • 41. Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation.
    Sugihara T; Hattori Y; Yamamoto Y; Qi F; Ichikawa R; Sato A; Liu MY; Abe K; Kanno M
    Circulation; 1999 Aug; 100(6):635-41. PubMed ID: 10441101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1.
    Marie I; Bény JL
    J Invest Dermatol; 2002 Dec; 119(6):1379-87. PubMed ID: 12485443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered coronary dilation in deoxycorticosterone acetate-salt hypertension.
    Millette E; de Champlain J; Lamontagne D
    J Hypertens; 2000 Dec; 18(12):1783-93. PubMed ID: 11132602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelium-derived relaxing and contracting factors.
    Furchgott RF; Vanhoutte PM
    FASEB J; 1989 Jul; 3(9):2007-18. PubMed ID: 2545495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
    Drexler H; Hayoz D; Münzel T; Just H; Zelis R; Brunner HR
    Arzneimittelforschung; 1994 Mar; 44(3A):455-8. PubMed ID: 8185723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
    Panza JA; Casino PR; Badar DM; Quyyumi AA
    Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The main determinants of endothelial dysfunction].
    Garaliene V
    Medicina (Kaunas); 2006; 42(5):362-9. PubMed ID: 16778463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of nitric oxide in bradykinin-induced dilation of coronary resistance vessels in patients with hypercholesterolemia.
    Kato M; Shiode N; Teragawa H; Hirao H; Yamada T; Yamagata T; Matsuura H; Kajiyama G
    Intern Med; 1999 May; 38(5):394-400. PubMed ID: 10397075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide.
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S37-40. PubMed ID: 10976779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular endothelium dysfunction: a conservative target in metabolic disorders.
    Jamwal S; Sharma S
    Inflamm Res; 2018 May; 67(5):391-405. PubMed ID: 29372262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Endothelium-derived relaxing factor/nitrogen oxide. Pharmacological and clinical cardiovascular aspects].
    Laursen JB; Boesgaard S; Poulsen HE; Aldershvile J
    Ugeskr Laeger; 1994 Sep; 156(39):5661-6. PubMed ID: 7985247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Endothelial functions in cardiovascular diseases].
    Mügge A; Förstermann U; Lichtlen PR
    Z Kardiol; 1989 Mar; 78(3):147-60. PubMed ID: 2652905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial dysfunction in normal and abnormal glucose metabolism.
    Esper RJ; Vilariño JO; Machado RA; Paragano A
    Adv Cardiol; 2008; 45():17-43. PubMed ID: 18230954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.
    Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
    Circulation; 1993 Dec; 88(6):2541-7. PubMed ID: 8252665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nebivolol: endothelium-mediated vasodilating effect.
    Ritter JM
    J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial dysfunction and vascular disease.
    Vanhoutte PM
    Verh K Acad Geneeskd Belg; 1998; 60(3):251-66. PubMed ID: 9803882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Endothelium-derived relaxing factor(s): endogenous nitrates in the circulation?].
    Lüscher TF; Yang Z; Diederich D; Schneider K; von Segesser L; Siebenmann R; Stulz P; Bühler FR
    Schweiz Med Wochenschr; 1988 Nov; 118(46):1724-9. PubMed ID: 3062771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1997 Mar; 120(5):757-62. PubMed ID: 9138678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.